Crinetics Pharmaceuticals (CRNX) Interest Coverage Ratio (2017 - 2026)

Crinetics Pharmaceuticals' Interest Coverage Ratio history runs 10 years deep, the most recent figure standing at 1.15 for Q1 2026.

• On a quarterly basis, Interest Coverage Ratio rose 97.93% year-over-year to 1.15 in Q1 2026; TTM through Mar 2026 was 4.49, a 99.35% increase from a year earlier, with the FY2025 full-year figure at 1.32, down 31.35% from the prior year.
• Interest Coverage Ratio slipped to 1.15 in Q1 2026 per CRNX's latest filing, from 40.43 in the prior quarter.
• Across five years, Interest Coverage Ratio topped out at 313.29 in Q4 2023 and bottomed at 158.52 in Q4 2022.
• The 5-year median for Interest Coverage Ratio is 0.78 (2022), against an average of 10.95.
• Across the five-year window, Interest Coverage Ratio jumped 297.63% in 2023 and slumped 25788.49% in 2025, its largest moves.
• Year by year, Interest Coverage Ratio stood at 158.52 in 2022, then soared by 297.63% to 313.29 in 2023, then sank by 80.5% to 61.09 in 2024, then sank by 33.81% to 40.43 in 2025, then slumped by 102.86% to 1.15 in 2026.
• Per Business Quant, the three latest CRNX Interest Coverage Ratio figures stand at 1.15 (Q1 2026), 40.43 (Q4 2025), and 0.71 (Q3 2025).